Pediatric Hematology and Oncology

Learning Objectives

• Describe the epidemiology, pathophysiology, clinical features, and treatment principles of acute lymphoblastic leukemia (ALL) in children.
• Differentiate iron deficiency anemia from other microcytic anemias in a child using history, examination, and basic labs.
• List the common pediatric solid tumors (Wilms tumor, neuroblastoma, retinoblastoma) and their classic presenting features.
• Recognize red-flag symptoms that should prompt urgent work-up for childhood malignancy.
• Interpret a basic CBC and peripheral smear to distinguish leukemia, anemia, and reactive processes.
• Outline the general approach to diagnosis and first-line management for the conditions covered.

Quick Answer

Pediatric hematology and oncology deals with blood disorders and cancers unique to children. The single most important malignancy to know is acute lymphoblastic leukemia (ALL) — the most common childhood cancer, presenting with fatigue, bruising, bone pain, and cytopenias, with cure rates now exceeding 85-90%. The most common hematologic problem overall is iron deficiency anemia, usually from poor dietary iron intake or cow's milk overconsumption in toddlers. Beyond leukemia, three solid tumors dominate pediatric oncology exams: Wilms tumor (abdominal mass), neuroblastoma (adrenal/sympathetic chain mass with catecholamine excess), and retinoblastoma (leukocoria). Recognizing red flags early — unexplained bruising, pallor, bone pain, persistent fever, or an abdominal mass — is the key clinical skill this topic tests.

Childhood Leukemia: Acute Lymphoblastic Leukemia (ALL)

Definition. ALL is a malignant clonal proliferation of immature lymphoid precursors (lymphoblasts) that crowd out normal bone marrow elements. It is the most common cancer of childhood, peaking between ages 2 and 5 years.

Explanation — how it develops. A single lymphoid progenitor acquires genetic mutations (chromosomal translocations, hyperdiploidy) that block normal maturation and drive uncontrolled proliferation. These blasts fill the bone marrow, suppressing normal erythropoiesis, granulopoiesis, and platelet production, and can infiltrate the liver, spleen, lymph nodes, CNS, and testes.

Clinical presentation. Symptoms stem directly from marrow failure and infiltration:

• Anemia → fatigue, pallor
• Neutropenia → recurrent or unusual infections, fever
• Thrombocytopenia → easy bruising, petechiae, gum bleeding
• Marrow expansion → bone and joint pain (children may refuse to walk)
• Infiltration → hepatosplenomegaly, lymphadenopathy, occasionally CNS signs (headache, vomiting) or testicular swelling

Diagnosis. CBC often shows anemia, thrombocytopenia, and a variable white cell count (can be low, normal, or very high). The peripheral smear shows lymphoblasts. Bone marrow aspirate confirming ≥25% (classically ≥20%) lymphoblasts is diagnostic, followed by immunophenotyping and cytogenetics (e.g., favorable ETV6-RUNX1 vs. high-risk BCR-ABL1 or hypodiploidy) to guide risk stratification.

Treatment. Multi-phase chemotherapy: induction (achieve remission), consolidation/intensification, CNS-directed therapy (intrathecal chemotherapy ± cranial radiation in high-risk cases), and maintenance therapy lasting roughly 2 years. Stem cell transplant is reserved for relapsed or very high-risk disease.

Real-world example. A 3-year-old brought in for "always tired and bruises like a peach" — normal toddler activity but new pallor, gum bleeding, and a limp because a bone lesion hurts to bear weight on. This constellation (cytopenias + bone pain) is the classic ALL vignette.

Why it matters. ALL is the pediatric cancer success story of modern medicine — 5-year survival has risen from under 10% in the 1960s to over 85-90% today because of risk-stratified, protocol-driven chemotherapy.

Common misunderstanding. Students assume the white cell count is always elevated in leukemia. In reality, the total WBC can be low, normal, or high — what matters is the differential showing blasts, not the total count.

Iron Deficiency Anemia in Children

Definition. A microcytic, hypochromic anemia resulting from insufficient iron for hemoglobin synthesis — the most common nutritional deficiency and the most common cause of anemia in childhood.

Explanation. Toddlers 9 months to 3 years are highest risk because rapid growth increases iron demand while diets (especially excess cow's milk, which is low in iron and can cause occult GI blood loss) fail to meet it. In adolescents, menstrual blood loss is an added risk factor.

Presentation. Often subtle: pallor, irritability, fatigue, poor feeding, and in longstanding cases, developmental or cognitive effects. Pica (craving non-food items like ice or dirt) is a classic clue. Severe cases may show koilonychia (spoon nails) or tachycardia.

Diagnosis. CBC shows low hemoglobin with low MCV (microcytic) and increased red cell distribution width (RDW) — a key differentiator from other microcytic anemias like thalassemia trait, where RDW is typically normal. Low serum ferritin confirms iron deficiency (ferritin is the most sensitive and specific routine test, though it is an acute phase reactant and can be falsely elevated with inflammation).

Real-world example. A well-fed but "picky" 18-month-old who drinks 32 oz of whole milk a day and eats almost no solid food — classic setup for milk-induced iron deficiency anemia.

Treatment. Oral ferrous sulfate (3-6 mg/kg/day elemental iron), dietary counseling to limit cow's milk to under 16-20 oz/day and introduce iron-rich solids, with a reticulocyte response expected within 5-7 days and hemoglobin normalization over 4-6 weeks.

Why it matters. Untreated iron deficiency in infancy is linked to lasting effects on cognitive and motor development, making early recognition and correction a genuine developmental priority, not just a lab abnormality.

Common misunderstanding. Many assume any microcytic anemia in a child needs iron. Always check ferritin or trial-and-response before committing a child with possible thalassemia trait to iron therapy, since iron overload in that setting is harmful and unnecessary.

Common Pediatric Solid Tumors

Definition. Solid tumors are malignancies arising outside the bone marrow/lymphoid system; in children, three "classic exam" tumors are Wilms tumor, neuroblastoma, and retinoblastoma.

Wilms Tumor (Nephroblastoma).

• Most common renal malignancy of childhood, typically age 2-5 years.
• Presents as an asymptomatic, smooth, unilateral abdominal mass often found incidentally by a parent or on exam; usually does NOT cross the midline.
• Associated with congenital syndromes: WAGR (Wilms, Aniridia, Genitourinary anomalies, Retardation), Beckwith-Wiedemann syndrome, and hemihypertrophy.
• Management: nephrectomy plus chemotherapy ± radiation; prognosis is excellent (>90% survival in localized disease).

Neuroblastoma.

• Most common extracranial solid tumor of childhood, arising from neural crest cells of the sympathetic chain (most often the adrenal medulla).
• Presents as an abdominal mass that CAN cross the midline, often with systemic signs from catecholamine secretion (hypertension, sweating, irritability) or paraneoplastic phenomena (opsoclonus-myoclonus, "dancing eyes"), and periorbital ecchymoses ("raccoon eyes") from orbital metastasis.
• Diagnosis aided by elevated urinary catecholamine metabolites (VMA, HVA) and characteristic "small round blue cells" on biopsy.
• Prognosis is highly variable — younger age and favorable biology (e.g., no MYCN amplification) predict better outcomes; MYCN amplification predicts aggressive disease.

Retinoblastoma.

• Most common intraocular malignancy of childhood, usually before age 2.
• Classic presentation: leukocoria (white pupillary reflex, often first noticed in flash photographs) replacing the normal red reflex; less commonly strabismus.
• Caused by biallelic loss of the RB1 tumor suppressor gene; the hereditary form is bilateral and multifocal (autosomal dominant with incomplete penetrance), while the sporadic form is unilateral.
• Treatment: enucleation for advanced unilateral disease, or eye-sparing approaches (chemotherapy, laser, cryotherapy) for smaller/bilateral tumors; survivors of hereditary retinoblastoma carry increased lifetime risk of secondary malignancies (e.g., osteosarcoma).

Why it matters. These three tumors are distinguished largely by whether the mass crosses the midline, associated syndromes, and characteristic signs (leukocoria, raccoon eyes, aniridia) — exactly the kind of pattern-recognition testable on exams.

Common misunderstanding. Students often mix up Wilms tumor and neuroblastoma. Remember: Wilms usually stays within the kidney capsule and doesn't cross the midline; neuroblastoma is more likely to cross the midline and cause systemic catecholamine effects.

Visual Learning: Red-Flag Pathway for Suspected Childhood Cancer

Key Terms

Term	Definition
Hematopoiesis	The process by which hematopoietic stem cells in the bone marrow produce all mature blood cell lines.
Lymphoblast	An immature lymphoid precursor cell; its malignant accumulation defines acute lymphoblastic leukemia.
Cytopenia	A reduction in one or more blood cell lines (anemia, neutropenia, thrombocytopenia), typically from marrow infiltration or failure.
Ferritin	An iron-storage protein; low serum ferritin is the most specific routine marker of iron deficiency.
RDW (red cell distribution width)	A measure of variability in red blood cell size; elevated in iron deficiency, typically normal in thalassemia trait.
Leukocoria	An abnormal white pupillary reflex, replacing the normal red reflex; the classic sign of retinoblastoma.
Catecholamine metabolites (VMA/HVA)	Breakdown products of catecholamines measured in urine to support a diagnosis of neuroblastoma.
MYCN amplification	An oncogene amplification in neuroblastoma associated with aggressive disease and worse prognosis.
Intrathecal chemotherapy	Chemotherapy injected into the cerebrospinal fluid to treat or prevent CNS involvement in leukemia.

Common Mistakes

Misconception	Why It's Wrong	Correct Understanding
"Leukemia always causes a very high white cell count."	The total WBC count is unreliable — it reflects a mix of normal cells and blasts and can be low, normal, or high.	Diagnosis relies on the differential and peripheral smear showing blasts, not the total WBC number.
"Any child with a low hemoglobin and small red cells needs iron supplementation."	Other microcytic anemias, especially thalassemia trait, look similar but do not need (and can be harmed by) iron therapy.	Check ferritin and RDW, or look at the response to a trial of iron, before committing to a diagnosis of iron deficiency.
"Wilms tumor and neuroblastoma are basically the same 'abdominal mass in a kid'."	They differ meaningfully in origin, midline crossing, systemic effects, and associated syndromes.	Wilms arises from the kidney, rarely crosses the midline, and is linked to WAGR/Beckwith-Wiedemann; neuroblastoma arises from the sympathetic chain, can cross the midline, and causes catecholamine-driven systemic signs.

Comparison and Connections

Feature	ALL (Leukemia)	Wilms Tumor	Neuroblastoma	Retinoblastoma
Peak age	2-5 years	2-5 years	<2 years (median ~17 months)	<2 years
Origin	Bone marrow lymphoid precursors	Kidney (nephroblastic tissue)	Sympathetic neural crest cells (often adrenal medulla)	Retina (RB1 gene loss)
Key presenting sign	Pallor, bruising, bone pain, cytopenias	Painless abdominal mass, does not cross midline	Abdominal mass, may cross midline; catecholamine effects	Leukocoria, absent red reflex
Associated syndromes	Down syndrome (higher risk)	WAGR, Beckwith-Wiedemann, hemihypertrophy	MYCN amplification (prognostic)	Hereditary RB1 mutation (bilateral)
First-line treatment	Multi-agent chemotherapy	Nephrectomy + chemotherapy	Surgery, chemotherapy, risk-based intensity	Enucleation or eye-sparing therapy

Practice Questions

Recall

1. What is the most common malignancy of childhood, and what cell type does it arise from? Answer guidance: Acute lymphoblastic leukemia (ALL); arises from immature lymphoid precursor cells (lymphoblasts) in the bone marrow.
2. Name the three classic pediatric solid tumors discussed and one hallmark feature of each. Answer guidance: Wilms tumor — painless abdominal mass not crossing midline; neuroblastoma — abdominal mass that may cross midline with catecholamine effects; retinoblastoma — leukocoria.

Understanding

3. Explain why the total white blood cell count is an unreliable indicator of leukemia. Answer guidance: The WBC count reflects the sum of normal and malignant cells; blasts can suppress normal production while circulating in variable numbers, so the count can be low, normal, or high — the differential and smear morphology are what confirm leukemia.
4. Why is RDW useful in distinguishing iron deficiency anemia from thalassemia trait? Answer guidance: Iron deficiency causes progressively more variable red cell sizes (high RDW) as iron stores deplete unevenly, whereas thalassemia trait produces uniformly small cells (normal RDW) because the defect is a fixed genetic reduction in globin chain synthesis.

Application

5. A 2-year-old is brought in because his mother noticed a white glow in his left eye in a flash photo. What is the most likely diagnosis and next step? Answer guidance: Retinoblastoma; next step is urgent ophthalmologic referral for dilated fundus examination (often under anesthesia) and imaging to assess for bilateral disease.
6. A 4-year-old presents with a painless, smooth abdominal mass on routine exam that does not cross the midline. What is the likely diagnosis and what test would you order first? Answer guidance: Wilms tumor; order an abdominal ultrasound (followed by CT/MRI for staging) and avoid excessive palpation, which can risk tumor rupture.

Analysis

7. Compare and contrast the mechanisms by which Wilms tumor and neuroblastoma cause their systemic clinical effects. Answer guidance: Wilms tumor's effects are largely mechanical/local (mass effect, possible hematuria, hypertension from renin secretion) and linked to genetic syndromes affecting kidney development; neuroblastoma's effects include hormonally active catecholamine secretion (hypertension, flushing, sweating) plus paraneoplastic and metastatic phenomena (opsoclonus-myoclonus, raccoon eyes), reflecting its origin in sympathetic neuroendocrine tissue.
8. A toddler has microcytic anemia with a normal RDW and a family history of a similar "mild anemia" that never responded to iron. What does this suggest, and how would you confirm it? Answer guidance: Suggests thalassemia trait rather than iron deficiency, since RDW is typically normal and there's a lack of response to iron in relatives; confirm with hemoglobin electrophoresis and a normal/adequate ferritin, avoiding unnecessary iron supplementation.

FAQ

1. Is childhood leukemia curable? Yes, in most cases. ALL now has cure rates of roughly 85-90% with modern risk-stratified chemotherapy protocols, making it one of the greatest success stories in pediatric oncology.

2. Why do toddlers get iron deficiency anemia so often? Rapid growth increases iron requirements right when many toddlers switch to diets heavy in cow's milk (low in iron, and can cause occult GI blood loss) and light in iron-rich solids like meat or fortified cereal.

3. How can you tell Wilms tumor and neuroblastoma apart on exam alone? Wilms tumor masses are typically smooth, unilateral, and confined without crossing the midline, whereas neuroblastoma masses can cross the midline and are more often accompanied by systemic signs like hypertension, irritability, or raccoon eyes.

4. Why does leukocoria matter so much in a young child? It is the classic warning sign of retinoblastoma, and because retinoblastoma is highly curable when caught early but sight- and life-threatening if missed, any parent-reported white pupillary reflex needs urgent ophthalmologic evaluation.

5. Does every child with anemia need a bone marrow biopsy? No. Most childhood anemia is iron deficiency, diagnosed and treated based on CBC, RDW, and ferritin. Bone marrow biopsy is reserved for cases with additional red flags like unexplained cytopenias in multiple lines, blasts on smear, or failure to respond to appropriate iron therapy.

Quick Revision

• ALL is the most common childhood cancer; presents with fatigue, pallor, bruising, bone pain, and cytopenias.
• Diagnose ALL with peripheral smear (blasts) and bone marrow aspirate (≥25% blasts); total WBC count can be low, normal, or high.
• ALL cure rates now exceed 85-90% with multi-phase chemotherapy including CNS-directed therapy.
• Iron deficiency anemia is the most common anemia in children, typically from excess cow's milk and poor iron intake in toddlers.
• Iron deficiency shows microcytosis, high RDW, and low ferritin; thalassemia trait shows microcytosis with normal RDW.
• Pica and irritability are classic clues to iron deficiency in a toddler.
• Wilms tumor: kidney origin, painless abdominal mass, does NOT cross midline, linked to WAGR and Beckwith-Wiedemann.
• Neuroblastoma: sympathetic chain/adrenal origin, mass CAN cross midline, catecholamine effects, raccoon eyes; MYCN amplification = worse prognosis.
• Retinoblastoma: leukocoria (absent red reflex), RB1 gene loss, hereditary form is bilateral, treat with enucleation or eye-sparing therapy.
• Red flags demanding urgent work-up: unexplained bruising/pallor, persistent bone pain, abdominal mass, leukocoria, and unremitting fever.
• Always distinguish local/mechanical tumor effects (Wilms) from hormonally active/paraneoplastic effects (neuroblastoma).

Related Topics

Prerequisites

• Normal hematopoiesis and blood cell development
• Basic CBC interpretation (RBC indices, WBC differential, platelet count)

Related Topics

• Bleeding and clotting disorders in children
• Sickle cell disease and other hemoglobinopathies
• General principles of pediatric oncologic emergencies (tumor lysis syndrome, febrile neutropenia)

Next Topics

• Pediatric infectious disease (since febrile neutropenia and infection risk overlap heavily with oncology)
• Genetics and inherited cancer syndromes in children